Literature DB >> 4538039

A clinicopathological study of human yellow fever.

T I Francis, D L Moore, G M Edington, J A Smith.   

Abstract

During an epidemic of yellow fever in the Jos Plateau area of Nigeria, 9 adult males with clinically diagnosed yellow fever were studied by haematological, biochemical, virological, serological, and liver biopsy methods. The ages of the patients ranged from 20 to 55 years and the duration of illness was 3-62 days. No virus was isolated from any patient but all patients should biochemical evidence of severe hepatocellular damage. Leucopenia was a feature of the late acute stage of the disease. Five sera had antibodies to yellow fever at titres greater than 1: 32, 3 of them being monospecific for yellow fever. The classical histological features of yellow fever were present only in the acute or late acute stages, when complement-fixation tests may be negative. With convalescence and the production of complement-fixing antibodies in high titres, the histological features resembled those of a persisting nonspecific hepatitis. In an endemic area, the histological features of yellow fever will depend on the stage of the disease and a picture of nonspecific hepatitis would not exclude yellow fever in the absence of confirmation from serological tests.

Entities:  

Mesh:

Year:  1972        PMID: 4538039      PMCID: PMC2480783     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  ZIKA VIRUS INFECTION IN MAN.

Authors:  D I SIMPSON
Journal:  Trans R Soc Trop Med Hyg       Date:  1964-07       Impact factor: 2.184

2.  Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.

Authors:  H GROOT; R B RIBERIRO
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

3.  Studies on the livers of yellow-fever-infected African monkeys.

Authors:  W G BEARCROFT
Journal:  J Pathol Bacteriol       Date:  1962-01

4.  The serological reactions in yellow fever.

Authors:  M THEILER; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-11       Impact factor: 2.345

5.  Yellow fever at Tema, Ghana, 1959: a serological survey by complement fixation.

Authors:  A FABIYI
Journal:  Ann Trop Med Parasitol       Date:  1961-07

6.  One-second needle biopsy of the liver.

Authors:  G MENGHINI
Journal:  Gastroenterology       Date:  1958-08       Impact factor: 22.682

7.  The Pathology of the Liver in Yellow Fiver.

Authors:  O Klotz; T H Belt
Journal:  Am J Pathol       Date:  1930-11       Impact factor: 4.307

Review 8.  One-second biopsy of the liver--problems of its clinical application.

Authors:  G Menghini
Journal:  N Engl J Med       Date:  1970-09-10       Impact factor: 91.245

  8 in total
  9 in total

1.  Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria.

Authors:  D E Carey; G E Kemp; J M Troup; H A White; E A Smith; R F Addy; A L Fom; J Pifer; E M Jones; P Brès; R E Shope
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

2.  Hepatic damage in neonatal rat due to E. coli endotoxin.

Authors:  R S Young; C Woods; J Towfighi
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

3.  Hepatitis Relapse after Yellow Fever Infection: Is There Another Wave?

Authors:  Fernanda Maria Farage Osório; Guilherme Grossi Lopes Cançado; Mateus Jorge Nardelli; Paula Vieira Teixeira Vidigal; Marcelo Antônio Pascoal Xavier; Wanessa Trindade Clemente
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-22       Impact factor: 1.581

4.  Disseminated mycosis in a patient with yellow fever.

Authors:  Gustavo Vieira Rodrigues Maciel; Marcelo Combat de Faria Tavares; Leonardo Soares Pereira; Guilherme Lima Castro Silva; Neimy Ramos de Oliveira; Eduardo Paulino; Marcelo Antonio Pascoal-Xavier
Journal:  Autops Case Rep       Date:  2018-08-13

5.  Zika virus replication and cytopathic effects in liver cells.

Authors:  Kenneth E Sherman; Susan D Rouster; Ling X Kong; Matthew T Aliota; Jason T Blackard; Gary E Dean
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

6.  Hepatitis Rebound after Infection with Yellow Fever Virus.

Authors:  Blandine Denis; David Chirio; Diane Ponscarme; Ségolène Brichler; Nathalie Colin de Verdière; François Simon; Jean-Michel Molina
Journal:  Emerg Infect Dis       Date:  2019-06-17       Impact factor: 6.883

7.  Late-Relapsing Hepatitis after Yellow Fever.

Authors:  Izabela Maurício Rezende; Leonardo Soares Pereira; Jordana Rodrigues Barbosa Fradico; Marcelo Antônio Pascoal Xavier; Pedro Augusto Alves; Ana Carolina Campi-Azevedo; Elaine Speziali; Lívia Zignago Moreira Dos Santos; Natalia Soares Albuquerque; Indiara Penido; Tayrine Araujo Santos; Ana Paula Dinis Ano Bom; Andrea Marques Vieira da Silva; Camilla Bayma Fernandes; Carlos Eduardo Calzavara; Erna Geessien Kroon; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Betânia Paiva Drumond
Journal:  Viruses       Date:  2020-02-17       Impact factor: 5.048

Review 8.  No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science.

Authors:  Monica Salerno; Francesco Sessa; Amalia Piscopo; Angelo Montana; Marco Torrisi; Federico Patanè; Paolo Murabito; Giovanni Li Volti; Cristoforo Pomara
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

9.  Yellow Fever Molecular Diagnosis Using Urine Specimens during Acute and Convalescent Phases of the Disease.

Authors:  Izabela Maurício de Rezende; Gabriela Fernanda Garcia Oliveira; Thaís Alkifeles Costa; Aslam Khan; Leonardo Soares Pereira; Tayrine Araújo Santos; Pedro Augusto Alves; Carlos Eduardo Calzavara-Silva; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Angelle Desiree LaBeaud; Betânia Paiva Drumond
Journal:  J Clin Microbiol       Date:  2022-08-02       Impact factor: 11.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.